Bareilly Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 19-12-2024
- Paid Up Capital ₹ 8.00 M
as on 19-12-2024
- Company Age 26 Year, 15 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.11 Cr
as on 19-12-2024
- Satisfied Charges ₹ 10.19 Cr
as on 19-12-2024
- Revenue -4.15%
(FY 2021)
- Profit 10.40%
(FY 2021)
- Ebitda -38.10%
(FY 2021)
- Net Worth 8.51%
(FY 2021)
- Total Assets -5.56%
(FY 2021)
About Bareilly Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.00 M.
The company currently has active open charges totaling ₹8.11 Cr. The company has closed loans amounting to ₹10.19 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pravin Singh and Naveen Singh serve as directors at the Company.
- CIN/LLPIN
U85110UP1998PTC024094
- Company No.
024094
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Dec 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Bareilly, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bareilly Diagnostics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pravin Singh  | Managing Director | 05-Mar-2014 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naveen Singh | Director | 15-Apr-2019 | Current |
Financial Performance of Bareilly Diagnostics.
Bareilly Diagnostics Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 4.15% decrease. The company also saw a substantial improvement in profitability, with a 10.4% increase in profit. The company's net worth moved up by a moderate rise of 8.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bareilly Diagnostics?
In 2021, Bareilly Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Doctor's Ct Scan And Stone Centre LimitedActive 29 years 10 monthsPravin Singh and Naveen Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Mar 2024 | ₹2.85 Cr | Open |
Others Creation Date: 24 May 2016 | ₹4.04 Cr | Open |
Others Creation Date: 13 Apr 2016 | ₹1.22 Cr | Open |
How Many Employees Work at Bareilly Diagnostics?
Bareilly Diagnostics has a workforce of 3 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bareilly Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bareilly Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
